Our mission is to combine synthetic biology and cell engineering to develop cell therapy approaches
Location: United States, Massachusetts, Cambridge
Employees: 1-10
Total raised: $65M
Investors 2
| Date | Name | Website |
| - | Humboldt | humboldtfu... |
| 10.05.2023 | Medical Ex... | medexcelca... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.09.2024 | Series A | $65M | - |
Mentions in press and media 5
| Date | Title | Description |
| 28.09.2024 | GC Therapeutics: Pioneering the Future of Cell Therapy with $65 Million in Funding | In the ever-evolving landscape of biopharmaceuticals, GC Therapeutics (GCTx) has emerged as a beacon of innovation. The Cambridge, MA-based company recently secured $65 million in Series A funding, a significant leap toward revolutionizing ... |
| 27.09.2024 | GC Therapeutics: $65 Million (Series A) Raised To Unlock The Next Generation Of Cell Therapy-Based Medicines | GC Therapeutics (GCTx) announced its launch to scale and unlock the next generation of cell therapy. And GCTx also completed a $65 million Series A financing led by Cormorant Asset Management with participation from Mubadala Capital, Andree... |
| 23.09.2024 | GC Therapeutics Raises $65M in Series A Funding | GC Therapeutics, a Cambridge, MA-based biopharmaceutical company advancing cell therapy-based medicines, raised $65M in Series A funding. The round was led by Cormorant Asset Management with participation from Mubadala Capital, Andreessen H... |
| 10.01.2022 | New Year, New Fund, New Opportunities in Bio + Health | 2021 saw higher than ever funding of startups, continued maturation of the tech-enabled bio and healthcare landscape, and new platforms and business models that propelled growing levels of adoption and scale amongst both upstarts and tradit... |
| - | GC Therapeutics | “GC Therapeutics” |